GlassScriptPhysician profile
Jesse E Bauwens
NPI 1730445230
$8,592.63
in general payments reported to CMS, 2019-2025
9 companies · $1,561 in 2025
The $1,561 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,524 · 2020: $275 · 2021: $387 · 2022: $2,675 · 2023: $718 · 2024: $451 · 2025: $1,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,731.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,107.17 | 2019-2025 | Mako, Ortholoc 3di, T2 Alpha |
| Medacta USA, INC. | $910.90 | 2020-2023 | Amistem |
| Zimmer Biomet Holdings, INC. | $256.73 | 2019-2022 | |
| Depuy Synthes Sales INC. | $142.55 | 2025 | Tfn-Advance, Na |
| Smith+Nephew, INC. | $54.37 | 2019 | |
| Orthofix Medical, INC. | $43.85 | 2024-2025 | Physio-Stim |
| Bioventus LLC | $32.77 | 2019 | |
| Convatec INC. | $24.13 | 2022 | |
| Vericel Corporation | $20.16 | 2025 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Bauwens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.